Evidence map›Paper›PMID 35836693›Full record

ArticleJournal of nutritional science2022

Amycenone reduces excess body weight and attenuates hyperlipidaemia by inhibiting lipogenesis and promoting lipolysis and fatty acid β-oxidation in KK-

Maya Kudo, Misa Hayashi, Boju Sun, Lili Wu, Tonghua Liu, Ming Gao

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nutritional science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Food & nutrition research · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Maya KudoSchool of Pharmaceutical Science, Mukogawa Women's University, 11-68 Koshien Kyuban-cho, Nishinomiya, Hyogo 663-8179, Japan.
Misa HayashiSchool of Pharmaceutical Science, Mukogawa Women's University, 11-68 Koshien Kyuban-cho, Nishinomiya, Hyogo 663-8179, Japan.
Boju SunSecond Clinical Medical College, Beijing University of Chinese Medicine, No. 11 North Third Ring East Road, Beijing 100029, China.
Lili WuCollege of Traditional Chinese Medicine, Beijing University of Chinese Medicine, No. 11 North Third Ring East Road, Beijing 100029, China.
Tonghua LiuSecond Clinical Medical College, Beijing University of Chinese Medicine, No. 11 North Third Ring East Road, Beijing 100029, China.
Ming GaoSchool of Pharmaceutical Science, Mukogawa Women's University, 11-68 Koshien Kyuban-cho, Nishinomiya, Hyogo 663-8179, Japan.
Beijing University of Chinese Medicine · CNMukogawa Women's University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Excess body weight and hyperlipidaemia cause severe health problems and have social implications. Amycenone is an active substance extracted from Yamabushitake mushrooms with no reports of its activity against excess body weight and hyperlipidaemia. This research clarifies the effects and mechanisms of action of amycenone on the inhibition of body weight excess and hyperlipidaemia attenuation using KK-

Indexed as

Diabetes Mellitus, ExperimentalHyperlipidemiasAMP-Activated Protein KinasesAnimalsBody WeightFatty AcidsLipogenesisLipolysisMaleMiceMice, ObeseObesityPlant ExtractsAMP-Activated Protein KinasesamycenoneFatty AcidsPlant ExtractsAmycenoneHepatic fat accumulationLipid metabolism pathwayObese/diabetes KK-Ay/TaJcl mice

Identifiers

PMID35836693
PMCPMC9274390
OpenAlexW4285049104

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.